SCHEDULE 13G
0002039349
XXXXXXXX
LIVE
Common Stock, par value $0.00001 per share
11/13/2025
0001994702
Kyverna Therapeutics, Inc.
501976104
5980 HORTON STREET
SUITE 550
EMERYVILLE
CA
94608
Rule 13d-1(c)
GordonMD Global Investments LP
b
DE
0.00
3058485.00
0.00
3058485.00
3058485.00
N
7.0
IA
PN
GordonMD Long Biased Master Fund LP
b
E9
0.00
2735783.00
0.00
2735783.00
2735783.00
N
6.2
PN
GordonMD Long Biased GP LLC
b
DE
0.00
2735783.00
0.00
2735783.00
2735783.00
N
6.2
OO
Craig D. Gordon
b
X1
0.00
3058485.00
0.00
3058485.00
3058485.00
N
7.0
HC
IN
GordonMD Global Investments GP LLC
b
DE
0.00
3058485.00
0.00
3058485.00
3058485.00
N
7.0
HC
OO
Kyverna Therapeutics, Inc.
5980 HORTON STREET, SUITE 550, EMERYVILLE, CA, 94608
GordonMD Global Investments LP
GordonMD Long Biased Master Fund LP
GordonMD Long Biased GP LLC
Craig D. Gordon
GordonMD Global Investments GP LLC
GordonMD Global Investments LP
9460 WILSHIRE BLVD, SUITE 420, BEVERLY HILLS, CA, 90212
GordonMD Long Biased Master Fund LP
9460 WILSHIRE BLVD, SUITE 420, BEVERLY HILLS, CA, 90212
GordonMD Long Biased GP LLC
9460 WILSHIRE BLVD, SUITE 420, BEVERLY HILLS, CA, 90212
Craig D. Gordon
9460 WILSHIRE BLVD, SUITE 420, BEVERLY HILLS, CA, 90212
GordonMD Global Investments GP LLC
9460 WILSHIRE BLVD, SUITE 420, BEVERLY HILLS, CA, 90212
GordonMD Global Investments LP - Delaware
GordonMD Long Biased Master Fund LP - Cayman Islands
GordonMD Long Biased GP LLC - Delaware
Craig D. Gordon - United States
GordonMD Global Investments GP LLC - Delaware
Y
GordonMD Global Investments LP - 3,058,485
GordonMD Long Biased Master Fund LP - 2,735,783
GordonMD Long Biased GP LLC - 2,735,783
Craig D. Gordon - 3,058,485
GordonMD Global Investments GP LLC - 3,058,485
GordonMD Global Investments LP - 7.0%
GordonMD Long Biased Master Fund LP - 6.2%
GordonMD Long Biased GP LLC - 6.2%
Craig D. Gordon - 7.0%
GordonMD Global Investments GP LLC - 7.0%
GordonMD Global Investments LP - 0
GordonMD Long Biased Master Fund LP - 0
GordonMD Long Biased GP LLC - 0
Craig D. Gordon - 0
GordonMD Global Investments GP LLC - 0
GordonMD Global Investments LP - 3,058,485
GordonMD Long Biased Master Fund LP - 2,735,783
GordonMD Long Biased GP LLC - 2,735,783
Craig D. Gordon - 3,058,485
GordonMD Global Investments GP LLC - 3,058,485
GordonMD Global Investments LP - 0
GordonMD Long Biased Master Fund LP - 0
GordonMD Long Biased GP LLC - 0
Craig D. Gordon - 0
GordonMD Global Investments GP LLC - 0
GordonMD Global Investments LP - 3,058,485
GordonMD Long Biased Master Fund LP - 2,735,783
GordonMD Long Biased GP LLC - 2,735,783
Craig D. Gordon - 3,058,485
GordonMD Global Investments GP LLC - 3,058,485
Y
N
All of the securities reported in this Schedule 13G are directly owned by advisory clients of GordonMD Global Investments LP. None of those advisory clients, other than GordonMD Long Biased Master Fund LP, may be deemed to beneficially own more than 5% of the Common Stock, par value $0.00001 per share.
N
Please see Exhibit B attached hereto.
Y
Y
N
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
Exhibit A - Joint Filing Agreement
Exhibit B - Control Person Identification
GordonMD Global Investments LP
/s/ GordonMD Global Investments GP LLC
Craig D. Gordon / Managing Member of the General Partner
11/17/2025
GordonMD Long Biased Master Fund LP
/s/ GordonMD Long Biased GP LLC
GordonMD Long Biased GP LLC / Managing Member of the General Partner
11/17/2025
GordonMD Long Biased GP LLC
/s/ Craig D. Gordon
Craig D. Gordon / Managing Member
11/17/2025
Craig D. Gordon
/s/ Craig D. Gordon
Craig D. Gordon
11/17/2025
GordonMD Global Investments GP LLC
/s/ Craig D. Gordon
Craig D. Gordon / Managing Member
11/17/2025
* Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
To the extent that "ownership of 5 percent or less of a class" was indicated in Item 5, such response only applies to the Reporting Person(s) that indicated elsewhere herein that it beneficially owns five percent (5%) or less of the class.